Maypharm Lifesciences Private Limited, a active private limited company, was established on 17 February 2016 in Mumbai City, Maharashtra, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U51101MH2016PTC273231. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.20 M.
It upholds a compliant status. Its leadership includes Ameya Anant Budukh (Director), Vijay Himatlal Doshi (Director), Jaynil Pankaj Doshi (Director). Past directors included Ameya Anant Budukh, Yash Himansu Bapat, Sameer Sidhram Kolhe. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 87 Vishal Industrial Estate Opp Ceat Tyres Village Bhandup West Mumbai 400078 Mh In, Mumbai City, Maharashtra, 400078.
U51101MH2016PTC273231
273231
17 February 2016
₹1.00 M
₹0.20 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Maypharm Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ameya Anant Budukh | Director | 26 Dec 2017 | Current |
| Vijay Himatlal Doshi | Director | 06 Aug 2019 | Current |
| Jaynil Pankaj Doshi | Director | 06 Aug 2019 | Current |
| Sameer Sidhram Kolhe | Managing Director | 17 Feb 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 26 Dec 2017 | Past |
| Pramod Abcsdd | Director | 03 Jun 2019 | Past |
| Pramod Abcsdd | Director | 13 Apr 2017 | Past |
| Pramod Abcsdd | Director | 13 Apr 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Maypharm Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 924.68% increase. The company also saw a substantial improvement in profitability, with a 80.88% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Maypharm Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Maypharm Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Maypharm Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maypharm Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Maypharm Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Maypharm Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on Vijay Himatlal Doshi was appointed as a Director was appointed as a Director on 06 Aug 2019 & has been associated with this company since 6 years 3 months . was documented.
Jaynil Pankaj Doshi was appointed as a Director was appointed as a Director on 06 Aug 2019 & has been associated with this company since 6 years 3 months . was recorded as a recent event.
Ameya Anant Budukh was appointed as a Director was appointed as a Director on 26 Dec 2017 & has been associated with this company since 7 years 11 months . was recorded as a recent event.
The activity Sameer Sidhram Kolhe was appointed as a Managing Director was appointed as a Managing Director on 17 Feb 2016 & has been associated with this company since 9 years 9 months . was completed.
The CIN of Maypharm Lifesciences Private Limited is U51101MH2016PTC273231.
Maypharm Lifesciences Private Limited is headquartered at 87 Vishal Industrial Estate Opp Ceat Tyres Village Bhandup West Mumbai 400078 Mh In, Mumbai City, Maharashtra, 400078.
Maypharm Lifesciences Private Limited was incorporated on 17 February 2016.
The current directors of Maypharm Lifesciences Private Limited are
The primary industry of Maypharm Lifesciences Private Limited is Hospital And Medical Care.
Maypharm Lifesciences Private Limited is unlisted.
The authorized capital of Maypharm Lifesciences Private Limited is ₹1.00 M, and the paid-up capital is ₹0.20 M.
The compliance status of Maypharm Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX